Section Arrow
CDTX.NASDAQ
- Cidara Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2024/05/15 02:56 EDT
Last
 13.09
+0.39 (+3.07%)
Day High 
13.44 
Prev. Close
12.7 
1-M High
17.6 
Volume 
28.57K 
Bid
12.21
Ask
13.1
Day Low
12.3301 
Open
12.6 
1-M Low
10.004 
Market Cap 
57.93M 
Currency USD 
P/E -- 
%Yield
10-SMA 12.65 
20-SMA 12.72 
50-SMA 14.89 
52-W High 29.6 
52-W Low 10.004 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.20/9.29
Enterprise Value
61.51M
Balance Sheet
Book Value Per Share
-1.80
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
63.91M
Operating Revenue Per Share
12.39
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8628+0.0221+2.63%-- 
JAGXJaguar Health0.2749-0.0154-5.30%-- 
NVAXNovavax13.48+0.37+2.82%-- 
SCPXScorpius Holdings0.0768-0.1047-57.69%-- 
RXRXRecursion Pharmaceuticals10.05+0.57+6.01%-- 
Quotes are at least 15-min delayed:2024/05/15 02:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's REZZAYO(R) (rezafungin for injection) is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.